Treatment of Balb/c mice injected with PC-9 or PC-9GR cells with 1 mg/mL metformin and 250 mg/L gefitinib for 30 days was found to block tumor growth of TKI-resistant xenografts, decrease IL-6 secretion and expression as well as reverse EMT [55]. This evidence concerns the gene IL6 and neoplasm.